Cubist Pharmaceuticals, Inc. (CBST) Tops Q3 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment deteriorates further in October
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
Jefferies Raises Price Target on Cubist (CBST) to $55
October 19, 2012 9:53 AM EDTJefferies reiterated a Buy rating on Cubist Pharmaceuticals (NASDAQ: CBST) and raised its price target to $55.00 (from $52.00).
Cubist it has 3 products in Ph3 development and analyst said they believe the stock is attractive based on the pipeline products potential.... More



